Statistics for VistaGen Therapeutics (id:5928 VTGN)
Valuation metrics
Market cap
73.23M
Enterprise value
-22,555,684.00
Trailing P/E (ttm)
-1.70
Forward P/E
-1.53
PEG ratio
-1.53
Price/Sales (ttm)
83.57
Price/Book (mrq)
0.77
Enterprise Value/Revenue
-25.74
Enterprise Value/EBITDA
0.50
Overview
Shares outstanding
27.84M
Float
16.30M
Shares short
528.16K
% Held by insiders
0.00%
% Held by institutions
0.54%
Average volume (10 days)
272.30K
Average volume (90 days)
Price summary
52-Week low
2.48
52-Week high
5.86
52-Week change
-39.15%
Beta
0.78
50-Day moving average
3.04
200-Day moving average
3.88
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
June 07th, 2023
Financials
Fiscal yearFiscal year ends
March 31th, 2024
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
-7,774.32%
Operational effectiveness
Return on assets
-39.40%
Return on equity
-61.52%
Income statement
Revenue (ttm)
0.03
Revenue per share (ttm)
0.03
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-45,466,300.00
Net income to common (ttm)
-39,565,300.00
Diluted EPS (ttm)
-0.74
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
97.58M
Total cash per share (mrq)
3.50
Total debt (mrq)
1.79M
Total Debt/Equity (mrq)
1.93
Current ratio (mrq)
1.33K%
Book value per share (mrq)
3.44
Cash flow
Cash flow statement
-33,487,400.00
Levered free cash flow (LFCF)
-23,333,300.00